Skip to content

APROPOS-II Study

APROPOS-II. A Stepped Wedge Cluster Randomized Controlled Trial to evaluate the effect of a locally tailored approach for Preconception Care.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26863
Enrollment
2167
Registered
2019-06-06
Start date
2019-06-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, patient tailored care, maternity care, antenatal care, maternal empowerment

Interventions

The intervention is locally tailored PCC approach. The key to this PCC approach is that it is tailored to the needs of prospective parents and healthcare providers in a local setting. To accomplish th

Sponsors

Erasmus Medical Centre - Rotterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, respondents must meet all of the following criteria: • Above the age of 18 years old • Pregnant women: presenting at participating midwifery practice for the booking visit • Prospective father: partner of the participating women.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study if: • Less than 18 years of age; • Inadequate mastery of the Dutch, English, Polish or Turkish language;

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study will be the improved uptake of PCC and improved lifestyle behaviours

Secondary

MeasureTime frame
Secondary outcomes will be the reduction of adverse pregnancy outcomes (e.g. miscarriage, preterm birth, gestational diabetes, etc.) and process evaluation, providing information on the efficacy and feasibility, barriers and facilitators for implementation of the PCC-approach.

Contacts

Public ContactVeronique Maas

Erasmus MC - Rotterdam

v.maas@erasmusmc.nl0650099474

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)